Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

---

Koklu S., Gulsen M. T., Tuna Y., Koklu H., Yuksel O., Demir M., ...More

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.41, no.3, pp.310-319, 2015 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 41 Issue: 3
• Publication Date: 2015
• Doi Number: 10.1111/apt.13036
• Journal Name: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.310-319
• Open Archive Collection: AVESIS Open Access Collection
• Gazi University Affiliated: Yes

Abstract

BackgroundResults are conflicting with respect to the renal effects of anti-viral agents used for hepatitis B virus infection.